BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12997204)

  • 21. The incorporation of serine-3-C14 into citrovorum factor.
    DOCTOR VM; AWAPARA J
    J Biol Chem; 1956 May; 220(1):161-7. PubMed ID: 13319335
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of ascorbic acid on the enzymatic formation of the citrovorum factor.
    NICHOL CA
    J Biol Chem; 1953 Sep; 204(1):469-75. PubMed ID: 13084617
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on the enzymatic release of citrovorum factor.
    HILL CH; SCOTT ML
    J Biol Chem; 1952 May; 196(1):189-93. PubMed ID: 12980956
    [No Abstract]   [Full Text] [Related]  

  • 24. Biological activity of a derivative of the citrovorum factor.
    CARTWRIGHT GE; WINTROBE MM; BROQUIST HP; JUKES TH
    Proc Soc Exp Biol Med; 1951 Nov; 78(2):563-7. PubMed ID: 14911953
    [No Abstract]   [Full Text] [Related]  

  • 25. The incorporation of formate-C14 into citrovorum factor.
    ZAKRZEWSKI SF; NICHOL CA
    J Biol Chem; 1955 Apr; 213(2):697-704. PubMed ID: 14367330
    [No Abstract]   [Full Text] [Related]  

  • 26. Leuconostoc citrovorum factor and the synthesis of serine by micro-organisms.
    LASCELLES J; CROSS MJ; WOODS DD
    Biochem J; 1951 Oct; 49(5):lxvi. PubMed ID: 14886375
    [No Abstract]   [Full Text] [Related]  

  • 27. [Associated citrovorum factor-aminopterin treatment in acute leukemia].
    CONSOLI G
    Sang; 1955; 26(4):426-34. PubMed ID: 13246578
    [No Abstract]   [Full Text] [Related]  

  • 28. [Citrovorum factor in x-ray-induced changes in the blood].
    CAFFARATTI E
    Radioter Radiobiol Fis Medica; 1951; 4(6):435-43. PubMed ID: 14942005
    [No Abstract]   [Full Text] [Related]  

  • 29. The occurrence of growth factors for Lactobacillus leichmannii; Streptococcus faecalis and Leuconostoc citrovorum in the tissues of pernicious anaemia patients and controls.
    GIRDWOOD RH
    Biochem J; 1952 Sep; 52(1):58-63. PubMed ID: 13018163
    [No Abstract]   [Full Text] [Related]  

  • 30. Orally administered citrovorum factor in the treatment of pernicious anemia with neurologic complications.
    MOORE NS; SCOTT ML; WALLACE CS; FIALA G
    N Y State J Med; 1951 Nov; 51(22):2645-6. PubMed ID: 14890905
    [No Abstract]   [Full Text] [Related]  

  • 31. Investigations on the biosynthesis of citrovorum factor by lactic acid bacteria.
    HENDLIN D; KODITSCHEK LK; SOARS MH
    J Bacteriol; 1953 Apr; 65(4):466-71. PubMed ID: 13069403
    [No Abstract]   [Full Text] [Related]  

  • 32. Microbiologic determination of folic acid derivatives in blood.
    GROSSOWICZ N; MANDELBAUM-SHAVIT F; DAVIDOFF R; ARONOVITCH J
    Blood; 1962 Nov; 20():609-16. PubMed ID: 13950839
    [No Abstract]   [Full Text] [Related]  

  • 33. Intravenous treatment of pernicious anemia with citrovorum factor (leucovorum).
    MEYER LM; DIFFENBACH WC; BRAHIN CM
    Proc Soc Exp Biol Med; 1951 Oct; 78(1):119-21. PubMed ID: 14891940
    [No Abstract]   [Full Text] [Related]  

  • 34. Synthesis of a substance exhibiting citrovorum factor activity by Lactobacillus arabinosus 17-5.
    MITBANDER VB; SREENIVASAN A
    Arch Mikrobiol; 1954; 21(1):69-79. PubMed ID: 13229325
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative effects of various antimetabolites on growth and synthesis of citrovorum factor by Streptococcus faecalis.
    WOOD RC; GELTZER A; HITCHINGS GH
    J Bacteriol; 1960 Feb; 79(2):306-7. PubMed ID: 13845829
    [No Abstract]   [Full Text] [Related]  

  • 36. The synthesis of serine and Leuconostoc citrovorum factor by cell suspensions of Streptococcus faecalis R.
    LASCELLES J; WOODS DD
    Biochem J; 1954 Nov; 58(3):486-97. PubMed ID: 13208641
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of ascorbic acid on the citrovorum factor-liberating enzyme of chick liver.
    HILL CH; SCOTT ML
    J Biol Chem; 1952 May; 196(1):195-9. PubMed ID: 12980957
    [No Abstract]   [Full Text] [Related]  

  • 38. Antimetabolite-metabolite cancer chemotherapy using continuous intra-arterial methotrexate with intermittent intramuscular citrovorum factor. Method of therapy.
    DUFF JK; SULLIVAN RD; MILLER E; ULM AH; CLARKSON BD; CLIFFORD P
    Cancer; 1961; 14():744-52. PubMed ID: 13724783
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of citrovorum factor upon tyrosine metabolism in clinical scurvy.
    GABUZDA GJ
    Proc Soc Exp Biol Med; 1952 Oct; 81(1):62-4. PubMed ID: 13047313
    [No Abstract]   [Full Text] [Related]  

  • 40. Antimetabolite-metabolite combination cancer chemotherapy. Effects of intraarterial methotrexate-intramuscular Citrovorum factor therapy in human cancer.
    SULLIVAN RD; MILLER E; SIKES MP
    Cancer; 1959; 12():1248-62. PubMed ID: 13835650
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.